XML 55 R30.htm IDEA: XBRL DOCUMENT
v3.25.4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Accounting Policies [Abstract] |
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash | The following table reconciles cash, cash equivalents and restricted cash reported within the Company's consolidated balance sheets to the total amounts reported in the consolidated statements of cash flows:
|  | December 31,
Reconciliation of cash, cash equivalents and restricted cash (in thousands) |  | 2025 |  | 2024 |  | 2023
Cash and cash equivalents |  | $ | 184,844 |  |  | $ | 51,870 |  |  | $ | 42,925 |
Restricted cash |  | 1,699 |  |  | 1,680 |  |  | 1,654 |
Total cash, cash equivalents and restricted cash |  | $ | 186,543 |  |  | $ | 53,550 |  |  | $ | 44,579 |
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash | The following table reconciles cash, cash equivalents and restricted cash reported within the Company's consolidated balance sheets to the total amounts reported in the consolidated statements of cash flows:
|  | December 31,
Reconciliation of cash, cash equivalents and restricted cash (in thousands) |  | 2025 |  | 2024 |  | 2023
Cash and cash equivalents |  | $ | 184,844 |  |  | $ | 51,870 |  |  | $ | 42,925 |
Restricted cash |  | 1,699 |  |  | 1,680 |  |  | 1,654 |
Total cash, cash equivalents and restricted cash |  | $ | 186,543 |  |  | $ | 53,550 |  |  | $ | 44,579 |
Schedule of Allowance for Credit Losses | The following table summarizes the activity related to the Company's allowance for credit losses (in thousands):
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
Beginning balance | $ | 1,212 |  |  | $ | 1,029 |  |  | $ | 1,106 |
Provision for bad debts | 1,479 |  |  | 877 |  |  | (77) |
Recoveries/(write-offs) | — |  |  | (695) |  |  | — |
Ending balance | $ | 2,691 |  |  | $ | 1,212 |  |  | $ | 1,029 |
Schedule of Revenue and Gross Accounts Receivable By Major Customer | Gross revenues and accounts receivable from each of the Company’s customers or collaboration partners who individually accounted for 10% or more of total gross revenues and/or 10% or more of total gross accounts receivable consisted of the following:
|  | % of Total Gross Revenues
|  | Years Ended December 31,
Customer |  | 2025 |  | 2024 |  | 2023
Fresenius Medical Care Rx |  | 30% |  | 48% |  | 40%
U.S. Renal Care |  | 29% |  | * |  | *
DaVita, Inc. |  | 25% |  | * |  | *
Cencora, Inc. |  | * |  | 19% |  | 21%
McKesson Corporation |  | * |  | 12% |  | 11%
Cardinal Health, Inc. |  | * |  | * |  | 10%
|  | % of Gross Accounts Receivable
|  | December 31,
Customer |  | 2025 |  | 2024
U.S. Renal Care |  | 42% |  | *
DaVita, Inc. |  | 29% |  | 16%
Fresenius Medical Care Rx |  | * |  | 42%
Cencora, Inc. |  | * |  | 13%
*Percentage less than 10% threshold.
Schedule of Estimated Useful Lives for Property, Plant and Equipment | Depreciation expense is recognized using the straight-line method over the estimated useful lives, which are typically:
Asset Category |  | Estimated Useful Life
Computer equipment and software |  | 3 years
Furniture and fixtures |  | 5 years | - | 7 years
Laboratory and other equipment |  | 7 years
Leasehold improvements |  | Shorter of the useful life or remaining lease term

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allowance for credit loss on accounts receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 8 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration